Found 468 results in Expert Content

Summary: This article explores the key factors pharmaceutical companies should consider when selecting a CDMO and evaluating its multi-product facility capable of handling HPAPIs to de-risk their programs and bring their products to patients safely.

Summary: This Q&A article explore challenges in HPAPI drug manufacturing & what to consider when partnering with a CDMO.

Summary: Discover how Catalent, a specialized CDMO, accelerates time to market for inhalation innovators with end-to-end solutions.

Summary: Catalent specializes in small molecule solid-state characterization, leveraging a vast network of scientists for successful drug candidate development by choosing the best API form.

Summary: Catalent has supported drug development since 1991, focusing on E&L. They use well-characterized materials to ensure drug product safety and quality.

Summary: Whether you are looking for accelerated development for your novel therapy, to transform your concepts into differentiated products to grow your brand, or lifecycle management to extend market share and maximize product value, Catalent can be your...

Gain valuable insights into the benefits of Zydis fast-dissolve technology and how it can optimize your product for commercial success.

Summary: This article discusses how to effectively classify highly potent APIs (HPAPIs), and to help develop containment protocols and manufacturing processes that are both safe and efficient.

Summary: This webinar aims to address the specific needs of sponsors by providing valuable insights and practical strategies. Experts will explore...

Summary: Zydis ODT offers rapid disintegration, a good mouthfeel and pleasant taste which plays a role in improving patient engagement in their treatment programs and offers an easy-to-take alternative to conventional oral tablets to help meet the needs of specific patient populations such as pediatric, geriatric and dysphagic patients.